HNRNPR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.009200E-01
Normal-vs-Stage2
4.831600E-01
Normal-vs-Stage3
2.541800E-01
Normal-vs-Stage4
5.281400E-01
Stage1-vs-Stage2
7.460800E-01
Stage1-vs-Stage3
5.942000E-01
Stage1-vs-Stage4
1.308440E-01
Stage2-vs-Stage3
4.017200E-01
Stage2-vs-Stage4
4.057600E-02
Stage3-vs-Stage4
1.540570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.852800E-01
Normal-vs-AfricanAmerican
9.303600E-01
Normal-vs-Asian
2.117600E-01
Caucasian-vs-AfricanAmerican
3.974400E-01
Caucasian-vs-Asian
2.585800E-01
AfricanAmerican-vs-Asian
1.541000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.823600E-01
Normal-vs-Female
5.027400E-01
Male-vs-Female
8.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.082600E-01
Normal-vs-Age(41-60Yrs)
8.545400E-01
Normal-vs-Age(61-80Yrs)
3.712800E-01
Normal-vs-Age(81-100Yrs)
1.247810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.029200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.223800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.708200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.375920E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.596200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.532000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.800550E-01
Normal-vs-Daily Drinker
4.437800E-01
Normal-vs-Weekly Drinker
2.632800E-01
Normal-vs-Occasional Drinker
9.112200E-01
Normal-vs-Social Drinker
4.618600E-01
Non Drinker-vs-Daily Drinker
6.172000E-01
Non Drinker-vs-Weekly Drinker
8.966000E-01
Non Drinker-vs-Occasional Drinker
4.559900E-02
Non Drinker-vs-Social Drinker
3.518200E-01
Daily Drinker-vs-Weekly Drinker
6.411400E-01
Daily Drinker-vs-Occasional Drinker
2.221600E-01
Daily Drinker-vs-Social Drinker
7.456600E-01
Weekly Drinker-vs-Occasional Drinker
1.159780E-01
Weekly Drinker-vs-Social Drinker
4.175600E-01
Occasional Drinker-vs-Social Drinker
3.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.455800E-01
Normal-vs-Grade 2
8.164600E-01
Normal-vs-Grade 3
7.910800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.143800E-02
Grade 1-vs-Grade 3
1.687640E-02
Grade 1-vs-Grade 4
9.455800E-01
Grade 2-vs-Grade 3
5.599800E-01
Grade 2-vs-Grade 4
8.164600E-01
Grade 3-vs-Grade 4
7.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.535000E-01
Normal-vs-NonDiabetic
3.915200E-01
Diabetic-vs-NonDiabetic
5.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.896000E-02
Normal-vs-NoPancreatitis
4.564200E-01
Pancreatitis-vs-NoPancreatitis
9.617800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.267200E-01
Normal-vs-N1
4.994800E-01
N0-vs-N1
8.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.615800E-01
Normal-vs-TP53-NonMutant
3.830800E-01
TP53-Mutant-vs-TP53-NonMutant
4.975600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
